Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance). - Marks, Jeffrey R.; Zhang, Dadong; Hardman, Timothy; Chen, Yunn-yi; Hall, Allison; Simpson, Lunden; Hieken, Tina; Bedrosian, Isabelle; Price, Elissa; Sheng, Jeff; Dai, Yanwan; Lee, Marissa; et al. (Breast Cancer Research, 2025)